Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by stanleyon Feb 01, 2012 10:06pm
182 Views
Post# 19477568

RE: Terry/Stanley -- Comments? String of Pearls

RE: Terry/Stanley -- Comments? String of Pearls

Kwel2:

Read the NI43-101today, and yes we appear to be be in the very early stage of a major "string of pearls". With Black Fox in the North and the Ross Mine to the South, lots of ore and potentially lots of spoils depositional area (in the exhausted OP's). Maybe they're keeping the project under the radar? But the DPFZ and splays could be the potential sites of Ross Mine(s) (53 yrs, 1936-1989).

1. Wiskey Jack Zone (200m north of the Contact Zone), testing below a distinct topo low, with the CO on November 24, 2011 with other results pending.

2. The Grey Fox Zone (Sec 10.1.3, GF10-115)

3. Hislop North (Sec 10.1.4, p 60 of 131)

4. Gold Pike Mine

Be sure to read Sections 15 & 18 for the potential upside.

BWDIK? Perfect target for T1 or T2 getting frustrated with operating overseas where governments are seeing dollar signs. Again, I re-iterate that the industry is facing serious (qualified) personnel shortages. On sage on BNN suggested that only operations with free cash flows (FCF) will get market's attention in this phase of this market volatility. Explains somewhat the lacklustre performance of the explorers and juniors not yet generating FCF. He did say that the POG will get to $2000 this year. I also believe that rotation from T1, T2, T3 will eventually discover that BRD could (eventually) make it to the ranks of the FCF producers.

GLTAL - GLAP

Cheers

Stanley

 

Bullboard Posts